The purpose of this observational, retrospective database study of patients with uterine fibroids is to compare the durability of symptom relief after uterus-conserving treatments for symptomatic fibroids in terms of incidence of, and time to, new or recurrent symptoms and subsequent procedures and evaluate the effect stakeholder participation had on the research process.

Inclusion Criteria:

• Female patients with a diagnosis of uterine fibroids at any time and at least 1 office visit during study time period
• At least 1 of the procedures of interest occurring between January 1, 2005 - December 31, 2011
• ≥ 18 years and < 55 years of age at the index date

Exclusion Criteria:

• Patients with a diagnosis of gynecologic cancer (ovarian, uterine, cervical)
• First recorded diagnosis of uterine fibroids occurring beyond four weeks after the Index Date ONLY for patients who underwent endometrial ablation or hysterectomy
• Patients with a record of any procedures of interest occurring before January 1, 2005

The patient population for the retrospective data analysis was uterine fibroid patients who have a record of at least 1 of the procedures of interest occurring during the time period of January 1, 2005 - December 31, 2011, with the first instance being designated as the index date. The study time period spanned from January 1, 2004 - December 31, 2013 to allow for 12 months pre-index for evaluating baseline demographic and clinical characteristics and 24 months post-index, ensuring a minimum of 2 years follow-up.